Zacks Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.8K | Buy |
+14,899
| New | +$30.8K | ﹤0.01% | 689 |
|
|
2024
Q4 | – | Sell |
-475,575
| Closed | -$946K | – | 721 |
|
|
2024
Q3 | $946K | Buy |
475,575
+11,320
| +2% | +$22.5K | 0.01% | 408 |
|
|
2024
Q2 | $1.62M | Buy |
464,255
+27,782
| +6% | +$97.2K | 0.02% | 316 |
|
|
2024
Q1 | $1.21M | Buy |
436,473
+125,044
| +40% | +$346K | 0.01% | 381 |
|
|
2023
Q4 | $529K | Buy |
+311,429
| New | +$529K | 0.01% | 459 |
|